clinical rationale for pi3k inhibitors in bc
Published 5 years ago • 187 plays • Length 6:13Download video MP4
Download video MP3
Similar videos
-
17:28
role of pi3k inhibitors in clinical practice: uses and pitfalls
-
3:59
role of pi3k inhibitors in treatment of b-cell malignancies
-
9:54
pi3k inhibition in breast cancer
-
3:39
role of pi3k inhibitors in hr metastatic breast cancer
-
6:21
pi3k inhibitors for hr breast cancer
-
2:02
pi3k inhibition for r/r follicular lymphoma
-
5:21
the emerging role of pi3k inhibition
-
4:43
pi3k inhibitors in hr metastatic breast cancer
-
7:47
common toxicities with pi3k inhibition
-
3:46
pi3k inhibitors in management of cll
-
4:49
pi3k inhibitors in r/r cll
-
8:04
chemotherapy and parp inhibitors in bc
-
1:41
the role of pi3k inhibitors in cll
-
4:28
pi3k inhibitors for hr metastatic breast cancer
-
12:07
pi3 kinase inhibitors for third-line therapy in fl
-
1:00:07
pi3k/akt pathway inhibition for the treatment of metastatic castrate-resistant prostate cancer
-
7:46
pi3k and parp inhibitors in hr metastatic breast cancer
-
5:33
managing toxicities of pi3k inhibitors in fl
-
42:18
targeting the pi3k pathway in the therapy of breast cancer - by jose baselga, md, phd